B/F/TAF Switch Study for HIV-HBV Coinfection
NCT03797014
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
28
Enrollment
OTHER
Sponsor class
Conditions
HIV-1-infection
Hepatitis B
Interventions
DRUG:
B/F/TAF
Sponsor
University of Maryland, Baltimore
Collaborators
[object Object]